Sizling Stock Update: Galectin Therapeutics, Inc. (NASDAQ:GALT) - FactsReporter
Insider Trades for Galectin Therapeutics, Inc. show that the latest trade was made on 9 Nov 2016 where 10X Fund, L.P., the Beneficial Owner of More than 10% Class completed a transaction type “Sell” in which 17096 shares were traded at a price of $0.78.
Healthcare Stocks Highlighted As Major Movers: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Galectin ... - TWN
Galectin Therapeutics, Inc. (GALT) opened the session with a $1.07 price tag, later ranging from $1.07 to $1.18, the range at which the stock has traded at throughout the day. The stock stands nearly $1.98 off versus the 52-week high of $3.05 and $0.58 ...altro »
Galectin Therapeutics Inc. (GALT) Upgraded by Zacks Investment Research to "Buy" - Sports Perspectives
Galectin Therapeutics logo Galectin Therapeutics Inc. (NASDAQ:GALT) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Tuesday. The brokerage presently has a $1.25 target price on the stock ...
These Brokerage Research Findings Are Noteworthy: Galectin ... - Review Fortune
Galectin Therapeutics, Inc. (NASDAQ:GALT) showed a growth of 7.55% from the market's prior closing price. That gain sent the price at $1.14 per share as of ...altro »
Stocks to Concentrate: Endo International plc (NASDAQ:ENDP) , Galectin Therapeutics Inc. (NASDAQ:GALT) - WsNews 4investors
Endo International plc (NASDAQ:ENDP) and showed negative change of +0.00% while the stock's final trade was registered at $ 13.19. However, its previous closing price was seen at $13.19. The stock negotiated total number of 0 shares as compared to 3 ...altro »
Markets End Mostly Higher, How Did This Stock Fare: Galectin Therapeutics, Inc. (NASDAQ:GALT) - Wall Street Beacon
Galectin Therapeutics, Inc. (NASDAQ:GALT) performed nicely this week, continuing its impressive near-term upward movement. The stock has moved north 8.57% over the past week of trading. Looking further out, over the past twelve months, Galectin ...altro »
GALECTIN THERAPEUTICS INC. (NASDAQ:GALT) Files An 8-K Entry into a Material Definitive Agreement - Market Exclusive
Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Company's drug candidates are based on its method of targeting galectin proteins, ...
Galectin Therapeutics Inc. (GALT) Lifted to Buy at Zacks Investment Research - The Cerbat Gem
Galectin Therapeutics (NASDAQ:GALT) traded up 5.9717% during midday trading on Tuesday, reaching $1.1233. 1,030,277 shares of the company's stock were exchanged. Galectin Therapeutics has a 1-year low of $0.49 and a 1-year high of $3.05.
Successful Option Trading: Galectin Therapeutics Inc (NASDAQ:GALT) Winning Short Put Spreads Can Outperform ... - CML News
There is a lot less 'luck' involved in successful option trading than many people have come to understand. We can get specific with short put spreads on GALT in this dossier. Let's look at a two-year back-test of a short put spread strategy and use the ...altro »
Street Session Update on Galectin Therapeutics Inc. (NASDAQ:GALT) - Liberty News
Let's take a quick look at where covering equity analysts see Galectin Therapeutics Inc. (NASDAQ:GALT) going in the future. Analysts polled by Thomson Reuters have a current consensus target on company stock of $1.12. It is important to mention that ...altro »